Sulfadiazine-induced crystalluria and renal failure in a patient with AIDS

Journal of the American Board of Family Practice

Volumn 12, Issue 3, 1999, Pages 243-248

  Dong, Betty J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; ETHAMBUTOL; FOLINIC ACID; PYRIMETHAMINE SULFADIAZINE; SAQUINAVIR; SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN EDEMA; CASE REPORT; CLINICAL FEATURE; CRYSTALLURIA; DISEASE PREDISPOSITION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYDRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LYMPHOCYTE COUNT; MALE; METABOLIC ACIDOSIS; NEPHROTOXICITY; NEUROPSYCHOLOGICAL TEST; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; TOXOPLASMOSIS; TREATMENT OUTCOME;

EID: 0033058492     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: 10.3122/jabfm.12.3.243     Document Type: Article

References (4)

1. Newton HB. Common neurologic complications of HIV-1 infection and AIDS. Am Fam Physician 1995;51:3 87-98.
2. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994; 121 : 769-85.
3. Katlama C, DeWit S, O'Doherty E, Van Glabeke M, Clumeck N. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996;22:268-75.
4. Wong SY, Israelski DM, Remington JS. AIDS-associated toxoplasmosis. In Sande MA, Volberding P, editors. Medical management of AIDS. 4th ed. Philadelphia: WB Saunders, 1995.